The 31 linked references in paper T. Geliashvili M., A. Vazhenin V., N. Afanas’eva G., Т. Гелиашвили М., А. Важенин В., Н. Афанасьева Г. (2017) “Основы применения совмещенной позитронно-эмиссионной и компьютерной томографии с 18-фтордезоксиглюкозой при дифференцированном раке щитовидной железы после первичного лечения // The use of 18F-fluorodeoxyglucose positron emission tomography combined with computed tomography in patients with differentiated thyroid cancer after initial treatment” / spz:neicon:ogsh:y:2017:i:1:p:12-21

  1. ПЭТ / КТ составила 78, 85 и 93 % соответственно [56].
  2. DOI: 10.1210/jc.2005-2838.
  3. DOI: 10.1102/1470-7330.2008.0007.
  4. DOI: 10.1530/EJE-15-0066.
  5. DOI: 10.1210/jc.2008-1747.
  6. DOI: 10.1089/thy.2011.0522.
  7. DOI: 10.1089/thy.2010.0178. 30. Cooper D.S., Doherty G.M., Haugen B.R. et al. Revised American Thyroid Association management gu
  8. DOI: 10.1089/thy.2009.0110.
  9. DOI: 10.1007/s40336-013-0024-0. 32. Leboulleux S., El Bez I., Borget I. et al. Postradioiodine treatment whole body
  10. DOI: 10.1089/thy.2012.0081. 33. Dong M.J., Liu Z.F., Zhao K. et al. Value of 18F-FDG-PET/PET-CT in differentiated thyroid carcinoma with radioiodine-n
  11. DOI: 10.1097/MNM.0b013e32832dcfa7.
  12. DOI: 10.1210/jc.2009-1567. 35. Giovanella L. Positron emission tomography/computed tomography in patients treated for differentiated thyroid carcinomas. Exp Rev Endocr
  13. DOI: 10.1586/eem.11.83. 36. Pacak K., Eisenhofer G., Goldstein D.S. Functional imaging of endocrine tumors: role of positron emission
  14. DOI: 10.1210/er.2003-0032.
  15. DOI: 10.1210/jc.2005-1534.
  16. DOI: 10.1677/ERC-10-0233. 39. Wang W., Larson S.M., Fazzari M. et al. Prognostic value of [18F] fluorodeoxyglucose positron emission tomographic scan
  17. DOI: 10.1210/jcem.85.3.6458.
  18. DOI: 10.1007/s00259-012-2065-4.
  19. DOI: 10.1097/RLU.0000000000000699.
  20. DOI: 10.1210/jcem.77.4.8408458.
  21. DOI: 10.1089/105072502760043459.
  22. DOI: 10.2214/AJR.13.11673. 47. Vural G.U., Akkas B.E., Ercakmak N. et al. Prognostic significance of FDG
  23. PET/CT on the follow-up of patients of differentiated thyroid carcinoma with negative 131I whole-body scan and elevated thyroglobulin levels: correlat
  24. DOI: 10.1097/RLU.0b013e31825b2057.
  25. Combined PET/CT in the follow-up of differentiated thyroid carcinoma: what is the impact of each modality? Eur J Nucl
  26. DOI: 10.1007/s00259-006-0276-2.
  27. DOI: 10.1097/RLU.0b013e3181b7d95c.
  28. DOI: 10.1007/s11604-010-0488-z. 53. Zimmer L.A., McCook B., Meltzer C. et al. Combined positron emission tomography/computed tomography imaging of recurre
  29. DOI: 10.1067/mhn.2003.74.
  30. DOI: 10.1007/s00259-013-2370-6.
  31. DOI: 10.1016/j.biopha.2006.07.008.